Vision
The Platform
Clinical Evidence
Leadership
News & Events
Investors
Careers
More
April 21, 2025
Field Medical Closes $40 Million Series A Financing to Redefine Pulsed Field Ablation for Ventricular Tachycardia
December 5, 2024
Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia
September 18, 2023
Field Medical Announces $14M Seed Round
March 15, 2023
Field Medical Expands Board of Directors
media@fieldmedicalinc.com
+1 (980) 412-2298